Mon, December 5, 2011
[ Mon, Dec 05th 2011 ] - Market Wire
New Data Demonstrating the Impact of Opioid-Relat .. spital Cost Presented at American Society of Heal
[ Mon, Dec 05th 2011 ] - Market Wire
Radient Pharmaceuticals' Two Abstracts Submitted .. cers Symposium (ASCO) Regarding Onko-Sure Utility
[ Mon, Dec 05th 2011 ] - Market Wire
68% of Healthcare Workers Believe Needlestick Inj .. blem According to a MedPro Safety Products Survey
Sun, December 4, 2011
[ Sun, Dec 04th 2011 ] - Market Wire
Two Year Results of Phase 3 Studies with EYLEAa" .. t AMD Show Sustained Improvement in Visual Acuity
Fri, December 2, 2011
[ Fri, Dec 02nd 2011 ] - Market Wire
Cigna International Expatriate Benefits Expande Rede de Atendimento de Sade no Brasil
[ Fri, Dec 02nd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Its Investigatio .. he Federal Securities Laws by Pacific Biosciences
[ Fri, Dec 02nd 2011 ] - Market Wire
Cigna International Expatriate Benefits tend son rseau de soins de sant au Brsil
[ Fri, Dec 02nd 2011 ] - Market Wire
Pfizer Completes Acquisition of Excaliard
[ Fri, Dec 02nd 2011 ] - Market Wire
MDxHealth Enters Agreement with Celldex for Use o .. t in Phase III Rindopepimut Study in Brain Cancer
[ Fri, Dec 02nd 2011 ] - Market Wire
Saxena White P.A. Represents Investors in Securit .. es Fraud Class Action Against China-Biotics, Inc.
[ Fri, Dec 02nd 2011 ] - Market Wire
ProAmatine (midodrine HCl) Update: Path Forward Agreed
[ Fri, Dec 02nd 2011 ] - Market Wire
Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011
[ Fri, Dec 02nd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky Launches an Inve .. ches of Fiduciary Duties and Unjust Enrichment by
[ Fri, Dec 02nd 2011 ] - Market Wire
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2012 Results
[ Fri, Dec 02nd 2011 ] - Market Wire
Graymark Healthcare Signs Milestone 100th Sleep Center Agreement
[ Fri, Dec 02nd 2011 ] - Market Wire
Skilled Healthcare Group to Present at the Oppenh .. Annual Healthcare Conference on December 13, 2011
[ Fri, Dec 02nd 2011 ] - Market Wire
CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device
[ Fri, Dec 02nd 2011 ] - Market Wire
Amerinet Awards Positron Group Purchasing Agreement
[ Fri, Dec 02nd 2011 ] - Market Wire
AdCare Health Systems Closes Acquisition of Skilled Nursing and Assisted Living Center in Arkansas
[ Fri, Dec 02nd 2011 ] - Market Wire
Concord Medical Announces Shareholder Resolutions .. ual General Meeting, Board and Management Changes
[ Fri, Dec 02nd 2011 ] - Market Wire
Micro Imaging Technology Announces the Results of the Annual General Shareholders Meeting
[ Fri, Dec 02nd 2011 ] - Market Wire
Trimel Pharmaceuticals Corporation Manufacturing Facility Receives GMP Compliance Designation
[ Fri, Dec 02nd 2011 ] - Market Wire
Medivir - TMC435 Will Be Evaluated in a Phase II .. latasvir (BMS 790052) for HCV Genotype-1 Patients
[ Fri, Dec 02nd 2011 ] - Market Wire
Mylan Launches Generic Version of Cyklokapron Injection
[ Fri, Dec 02nd 2011 ] - Market Wire
Oncolytics Biotech Inc. Announces Phase 2 Clinica .. ation with Gemcitabine in Pancreatic Cancer Reach
[ Fri, Dec 02nd 2011 ] - Market Wire
The Ensign Group Acquires Colorado Home Health Company
[ Fri, Dec 02nd 2011 ] - Market Wire
Kraig Biocraft Laboratories to Host Shareholder C .. duct, Scientific and Commercialization Developmen
[ Fri, Dec 02nd 2011 ] - Market Wire
Pharmacyclics Appoints Chief Medical Officer Dr. Lori Anne Kunkel
Thu, December 1, 2011
[ Thu, Dec 01st 2011 ] - Market Wire
MiMedx Group, Inc. to Present at the 6th Annual C .. ar, Aesthetics and Metabolic Disorders Conference
[ Thu, Dec 01st 2011 ] - Market Wire
Novadaq to Present at the Canaccord Genuity 6th Annual Medical Device Conference
[ Thu, Dec 01st 2011 ] - Market Wire
Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
[ Thu, Dec 01st 2011 ] - Market Wire
RepliCel to Present at the 4th Annual LD MICRO Growth Conference in Los Angeles, California
[ Thu, Dec 01st 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in The Copper Companies, Inc. to Inquir
[ Thu, Dec 01st 2011 ] - Market Wire
Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
[ Thu, Dec 01st 2011 ] - Market Wire
Celsion Corporation to Raise $15 Million in Private Placement
[ Thu, Dec 01st 2011 ] - Market Wire
Novelos Therapeutics Prices $5.9 Million Public Offering
[ Thu, Dec 01st 2011 ] - Market Wire
Direction of Market Influences - Report Highlights Abbott Laboratories and Novartis AG (ADR)
[ Thu, Dec 01st 2011 ] - Market Wire
Cleveland BioLabs to Present at 4th Annual LD MICRO Growth Conference
[ Thu, Dec 01st 2011 ] - Market Wire
DiaMedica's DM-204 for Type 2 Diabetes Significan .. od Glucose, Blood Pressure and Cholesterol Levels
[ Thu, Dec 01st 2011 ] - Market Wire
ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188
[ Thu, Dec 01st 2011 ] - Market Wire
Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day
[ Thu, Dec 01st 2011 ] - Market Wire
Lead Drug Candidates From Galena Biopharma and Ar .. a Pharmaceuticals Look to Make Big Splash in 2012
[ Thu, Dec 01st 2011 ] - Market Wire
Equity Research on HEALTHSOUTH Corp. and DaVita I .. lized Health Services Look to Add to Recent Gains
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Confirms First-to-File Patent Challenge Relating to Generessa" Fe
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Launches Generic Version of Caduet Tablets
[ Thu, Dec 01st 2011 ] - Market Wire
Stellar to Acquire Tribute Pharmaceuticals to Cre .. r North American Specialty Pharmaceutical Company
[ Thu, Dec 01st 2011 ] - Market Wire
MedCath Announces Sale of Ownership Interest in Harlingen Medical Center and HMC Realty, LLC
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Committed to Expanding Access in Developing .. es to High Quality, Affordable HIV/AIDS Treatment
[ Thu, Dec 01st 2011 ] - Market Wire
Auxilium Pharmaceuticals, Inc. Announces First Pa .. sed in XIAFLEX Study for Frozen Shoulder Syndrome
[ Thu, Dec 01st 2011 ] - Market Wire
Ceregene Completes Enrollment of Second Phase 2 S .. CERE-120 for the Treatment of Parkinson's Disease
[ Thu, Dec 01st 2011 ] - Market Wire
Titan Pharmaceuticals Confirms Regulatory Guidance for Probuphine
[ Thu, Dec 01st 2011 ] - Market Wire
VIVUS to Present at the Deutsche Bank BioFEST Conference
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Universal Health Services, Inc. Announces Agreement to Acquire Knapp Medical Center
[ Wed, Nov 30th 2011 ] - Market Wire
Uroplasty to Present at the Canaccord Genuity 6th .. etics & Metabolic Disorders Medical Device Confer
[ Wed, Nov 30th 2011 ] - Market Wire
PPD Announces Shareholder Approval of Merger with .. iates of The Carlyle Group and Hellman & Friedman
[ Wed, Nov 30th 2011 ] - Market Wire
Sunrise Senior Living Celebrates 30th Anniversary
[ Wed, Nov 30th 2011 ] - Market Wire
MSA Awarded Self-Contained Breathing Apparatus Contract from Pittsburgh Bureau of Fire
[ Wed, Nov 30th 2011 ] - Market Wire
Novadaq and KCI Sign Commercialization Agreements for the SPY System
[ Wed, Nov 30th 2011 ] - Market Wire
BIOLASE Issued Broad New Patent for Treating Eye .. ons, Including Presbyopia, Cataracts and Glaucoma
[ Wed, Nov 30th 2011 ] - Market Wire
Analytical Reports on Celgene Corporation and Bio .. flux of New Products and Uses in Biotech Industry
[ Wed, Nov 30th 2011 ] - Market Wire
Cytori's Celution(R) One Receives European CE Mark Approval
[ Wed, Nov 30th 2011 ] - Market Wire
Cytokinetics Announces Positive Results From Phas .. g CK-2017357 in Patients With Amyotrophic Lateral
[ Wed, Nov 30th 2011 ] - Market Wire
Marina Biotech to Remain Listed on The NASDAQ Global Market
[ Wed, Nov 30th 2011 ] - Market Wire
ProMetic Provides Update on Its Plasma-Derived Pr .. enture With China National Biotech Group ("CNBG")
[ Wed, Nov 30th 2011 ] - Market Wire
Palatin Technologies to Present at Windhover's Therapeutic Area Partnerships Conference
[ Wed, Nov 30th 2011 ] - Market Wire
United States Patent and Trademark Office Upholds .. Patents in Two Re-Examination Cases Brought by Is
[ Wed, Nov 30th 2011 ] - Market Wire
Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs
[ Wed, Nov 30th 2011 ] - Market Wire
FONAR Sells UPRIGHT Multi-Position MRI Scanner to .. hased Dynamic Weight-Bearing Multi-Position MRI T
[ Wed, Nov 30th 2011 ] - Market Wire
Given Imaging Files Patent Infringement Lawsuit in Korea Against Intromedic
[ Wed, Nov 30th 2011 ] - Market Wire
Curis Announces Agreement with The Leukemia & Lym .. evelop CUDC-907 for Lymphoma and Multiple Myeloma
[ Wed, Nov 30th 2011 ] - Market Wire
Compugen Presents Predictive Drug Target Discovery Platform at European Antibody Conference
[ Wed, Nov 30th 2011 ] - Market Wire
Soliris (culizumab) obtient une autorisation de m .. ur le traitement des patients atteints du syndrom
[ Wed, Nov 30th 2011 ] - Market Wire
Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator
[ Wed, Nov 30th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at World Epigenetics Summit on December 8th
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
[ Tue, Nov 29th 2011 ] - Market Wire
Ceapro Reports Third Quarter 2011 Financial Results
[ Tue, Nov 29th 2011 ] - Market Wire
Natural Alternatives International, Inc. Announce .. Beta-Alanine Patent Protecting CarnoSyn Products
[ Tue, Nov 29th 2011 ] - Market Wire
NeuroMetrix to Present at Canaccord Genuity 6th A .. ular, Aesthetics & Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
Cubist Pharmaceuticals to Present at December 2011 Investor Conferences
[ Tue, Nov 29th 2011 ] - Market Wire
IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
[ Tue, Nov 29th 2011 ] - Market Wire
Health Net Hosts 20th Annual Celebration of Children
[ Tue, Nov 29th 2011 ] - Market Wire
Dendreon and Human Genome Sciences - Ready to Turn Fortunes Around
[ Tue, Nov 29th 2011 ] - Market Wire
EnteroMedics to Present at the Canaccord Genuity .. ar, Aesthetics and Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
WeedMaps Announces Acquisition of Domain Name Marijuana.com
[ Tue, Nov 29th 2011 ] - Market Wire
Cytokinetics Announces Opening of Third Phase II .. 57 in Patients With Amyotrophic Lateral Sclerosis
[ Tue, Nov 29th 2011 ] - Market Wire
FDA Accepts ELIQUIS (apixaban) New Drug Applicati .. ion of Stroke and Systemic Embolism in Patients w
[ Tue, Nov 29th 2011 ] - Market Wire
Warnex Announces Resignation of Its President &;; CEO
[ Tue, Nov 29th 2011 ] - Market Wire
Horizon Pharma Announces U.S. Food and Drug Admin .. RA(R) New Drug Application for Review for the Tre
[ Tue, Nov 29th 2011 ] - Market Wire
Warnex Closes Transactions to Amend the Terms of .. ing Debentures and to Obtain Additional Financing
[ Tue, Nov 29th 2011 ] - Market Wire
Compugen and DiscoveRx Form Collaboration to Comm .. alize Novel Peptide Ligands for GPCR Drug Targets
[ Tue, Nov 29th 2011 ] - Market Wire
Omeros Announces Submission to European Medicines .. ic Investigation Plan Letter of Intent for OMS302
[ Tue, Nov 29th 2011 ] - Market Wire
Inhibitex Reports Recent Clinical and Corporate Developments
[ Tue, Nov 29th 2011 ] - Market Wire
Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference
[ Tue, Nov 29th 2011 ] - Market Wire
ONGLYZA (saxagliptina) aprobado para su utilizaci .. combinacin con insulina (con o sin metformina) en
[ Tue, Nov 29th 2011 ] - Market Wire
Radient Pharmaceuticals Corporation Completes Res .. al Investors to Limit Conversions and Stock Sales
[ Tue, Nov 29th 2011 ] - Market Wire
Exelixis Announces Webcast of Annual R&D Day on This Thursday, December 1
[ Tue, Nov 29th 2011 ] - Market Wire
Perceptive Informatics DataLabs EDC Solution Ranks Highest in Overall Satisfaction
[ Tue, Nov 29th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Mon, November 28, 2011
[ Mon, Nov 28th 2011 ] - Market Wire
Mesa Labs to Present at the 4th Annual LD MICRO Growth Conference
[ Mon, Nov 28th 2011 ] - Market Wire
Teva to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Mon, Nov 28th 2011 ] - Market Wire
New Reimbursement Codes Introduced to Better Trac .. Treating Patients with Severely Calcified Lesions
[ Mon, Nov 28th 2011 ] - Market Wire
Lightlake Therapeutics Inc. Launches New Corporat .. Host Investor Conference Call With Q & A Session
[ Mon, Nov 28th 2011 ] - Market Wire
Bacterin Signs Distribution Agreement with Jeil for 'LeForte Craniomaxillofacial System'
[ Mon, Nov 28th 2011 ] - Market Wire
Celsion Announces Unanimous Recommendation by Ind .. ittee to Continue and Complete Phase III HEAT Stu
[ Mon, Nov 28th 2011 ] - Market Wire
Brookwater Files Fiscal Year-End Financials and A .. Wagner Freire to the Forbes &;; Manhat
[ Mon, Nov 28th 2011 ] - Market Wire
Cytori Therapeutics Announces Participation in th .. eting on the Mesa's Investor and Partnering Forum
[ Mon, Nov 28th 2011 ] - Market Wire
ONGLYZA (saxagliptin) approvato per l'uso in Euro .. one con insulina (con o senza metformina) negli a
[ Mon, Nov 28th 2011 ] - Market Wire
ONGLYZA (saxagliptin) goedgekeurd voor gebruik in .. e met insuline (met of zonder metformine) bij vol
[ Mon, Nov 28th 2011 ] - Market Wire
ONGLYZA (saxagliptin) Approved for Use in Europe .. nsulin (With or Without Metformin) in Adults With
[ Mon, Nov 28th 2011 ] - Market Wire
Mindray Announces Partnership with Epiphany Cardiography Products, LLC
[ Mon, Nov 28th 2011 ] - Market Wire
ARIAD to Present at the 2011 Deutsche Bank BioFEST
[ Mon, Nov 28th 2011 ] - Market Wire
Life Technologies Makes Fluorescence Microscopy Accessible to All Scientists
[ Mon, Nov 28th 2011 ] - Market Wire
Catheterization and Cardiovascular Interventions Journal Publishes Results from USpella Registry
[ Mon, Nov 28th 2011 ] - Market Wire
FDA Grants IND to Investigator at Baylor College .. r Phase 2A Trial with AEZS-130 in Cancer Cachexia
[ Mon, Nov 28th 2011 ] - Market Wire
POZEN Monetizes Its Treximet Royalty Stream for $75 Million
[ Mon, Nov 28th 2011 ] - Market Wire
Micromet Initiates Global Phase 2 Trial of Blinat .. Relapsed/Refractory Acute Lymphoblastic Leukemia
[ Mon, Nov 28th 2011 ] - Market Wire
ArthroCare Announces Agreement in Principle to Settle Securities Class Action
[ Mon, Nov 28th 2011 ] - Market Wire
US Patent Office Rejects All 191 Claims in Key Mo .. oSol Patent Asserted Against BioDelivery Sciences
[ Mon, Nov 28th 2011 ] - Market Wire
OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference
[ Mon, Nov 28th 2011 ] - Market Wire
Exelixis Signs CRADA With National Cancer Institute to Expand Development Plan of Cabozantinib
[ Mon, Nov 28th 2011 ] - Market Wire
ShangPharma to Attend Two Upcoming Investor Conferences
Sun, November 27, 2011
[ Sun, Nov 27th 2011 ] - Market Wire
Regeneron and Bayer Initiate Phase 3 Clinical Pro .. of Wet Age-Related Macular Degeneration in China
[ Sun, Nov 27th 2011 ] - Market Wire
Hologic Introduces Synthesized 2D Image Algorithm .. ed for a 2D Mammogram in a 2D plus 3D Tomosynthes
Fri, November 25, 2011
[ Fri, Nov 25th 2011 ] - Market Wire
Cytokinetics Files Replacement Shelf Registration Statement
[ Fri, Nov 25th 2011 ] - Market Wire
PharmaGap Liposomal Formulations Achieve Key Milestones for Clinical Trials
[ Fri, Nov 25th 2011 ] - Market Wire
Mindray to Hold Annual General Meeting in Hong Kong on December 19, 2011
[ Fri, Nov 25th 2011 ] - Market Wire
Celgene Corporation to Present at the Piper Jaffray Health Care Conference 2011
Thu, November 24, 2011
[ Thu, Nov 24th 2011 ] - Market Wire
RepliCel Class C Shareholders Convert Into Common Shares
[ Thu, Nov 24th 2011 ] - Market Wire
Theratechnologies Wins ADRIQ's 2011 Product Innovation Award
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
Cynapsus Announces Parkinson's Drug Candidate Progress and Upcoming Milestones
[ Wed, Nov 23rd 2011 ] - Market Wire
Imaging Diagnostic Sells CTLM System to Mexico;; First of Five Systems to Be Installed
[ Wed, Nov 23rd 2011 ] - Market Wire
Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Derma Sciences to Present at the Piper Jaffray 23rd Annual Healthcare Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Impax Laboratories to Present at the Piper Jaffray 23rd Annual Healthcare Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
ProMetic Receives Confirmation of Octaplas(R)LG Regulatory Approval in Additional E.U. Countries
[ Wed, Nov 23rd 2011 ] - Market Wire
Medivation Announces Participation at Three Upcoming Investor Conferences
[ Wed, Nov 23rd 2011 ] - Market Wire
Alexion to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Antares Pharma, Inc., Global Cash Access Holdings .. , Raptor Pharmaceuticals Corp. and TASER Internat
[ Wed, Nov 23rd 2011 ] - Market Wire
Aetna, McDermott International, Kellogg, General Mills and Ralcorp Holdings
[ Wed, Nov 23rd 2011 ] - Market Wire
First Patient Dosed in Cervical Region in Neuralstem ALS Stem Cell Trial
[ Wed, Nov 23rd 2011 ] - Market Wire
A Change in Tides - Featured Research on Medtronic, Inc. and St. Jude Medical, Inc.
[ Wed, Nov 23rd 2011 ] - Market Wire
Smart-Tek Solutions, Inc. Expects to Recapture Revenue by Next Quarter
[ Wed, Nov 23rd 2011 ] - Market Wire
Endo Pharmaceuticals to Present at the Bank of Am .. a Merrill Lynch 2011 Leveraged Finance Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Dynavax and Vical -- Undervalued and Gaining Attention
[ Wed, Nov 23rd 2011 ] - Market Wire
Aeterna Zentaris and Hikma Pharmaceuticals Sign a .. ing Agreement for Lead Oncology Compound, Perifos
[ Wed, Nov 23rd 2011 ] - Market Wire
AcelRx Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Isis Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Arrowhead Research Appoints Drs. David Lewis and .. Rozema to Lead Operations at Madison, WI Facility
[ Wed, Nov 23rd 2011 ] - Market Wire
Covidien to Present at Piper Jaffray Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
HeartWare to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
PAREXEL Strengthens Late Phase and Observational .. pert Team to Help Biopharma Meet Commercializatio
[ Wed, Nov 23rd 2011 ] - Market Wire
00 a.m. EST
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
Cadence Pharmaceuticals Announces Completion of P .. k, Including Full Exercise of Over-Allotment Opti
[ Tue, Nov 22nd 2011 ] - Market Wire
Shire Announces Regulatory Filings in US and EU for New Manufacturing Facility
[ Tue, Nov 22nd 2011 ] - Market Wire
AmSurg Corp. to Present at the Piper Jaffray 23rd Annual Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Mettler-Toledo International Inc. Announces Webca .. f Presentation at J.P. Morgan SMid Cap Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Prana Receives Approval for Alzheimer's Trial
[ Tue, Nov 22nd 2011 ] - Market Wire
Daxor Announces That Harborview Medical Center of .. eattle, WA Acquires BVA-100 Blood Volume Analyzer
[ Tue, Nov 22nd 2011 ] - Market Wire
Sirona Biochem's French Subsidiary Receives CDN$1.9-Million Grant for Cosmeceutical Project
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
[ Tue, Nov 22nd 2011 ] - Market Wire
Equity Research on Pfizer Inc. and Bristol-Myers .. acturers Focus on R&;;D and Emerging Ma
[ Tue, Nov 22nd 2011 ] - Market Wire
Peregrine Reports Promising 23.2 Month Median Ove .. rvival From Phase II Advanced Breast Cancer Trial
[ Tue, Nov 22nd 2011 ] - Market Wire
MethylGene to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Pfizer to Acquire Excaliard Pharmaceuticals
[ Tue, Nov 22nd 2011 ] - Market Wire
Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals
[ Tue, Nov 22nd 2011 ] - Market Wire
MELA Sciences to Present at Piper Jaffray 23rd Annual Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Spectranetics to Present at the 23rd Annual Piper Jaffray Healthcare Conference on November 29
[ Tue, Nov 22nd 2011 ] - Market Wire
Pacira Pharmaceuticals, Inc. Announces Completion .. ommon Stock and Exercise of Over-Allotment Option
[ Tue, Nov 22nd 2011 ] - Market Wire
Acorda Therapeutics to Present at the Piper Jaffray 23rd Annual Healthcare Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
Exelixis Announces November 29th Webcast of Prese .. ation at the Piper Jaffray Health Care Conference
[ Tue, Nov 22nd 2011 ] - Market Wire
UnitedHealthcare to Acquire XLHealth
[ Tue, Nov 22nd 2011 ] - Market Wire
Astex Pharmaceuticals to Present at Piper Jaffray Health Care Conference on November 29th
[ Tue, Nov 22nd 2011 ] - Market Wire
Lexicon Announces Commencement of Rights Offering to Stockholders
[ Tue, Nov 22nd 2011 ] - Market Wire
PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
[ Tue, Nov 22nd 2011 ] - Market Wire
Comprehensive Care Corporation Signs New Multi-St .. e, Multi-Service Contract With Essence Healthcare
Mon, November 21, 2011
[ Mon, Nov 21st 2011 ] - Market Wire
Covidien anuncia acuerdo definitivo para comprar B'RRX Medical, Inc.
[ Mon, Nov 21st 2011 ] - Market Wire
Covidien anuncia acordo definitivo para aquisio da B'RRX Medical, Inc.
[ Mon, Nov 21st 2011 ] - Market Wire
Steps in the Right Direction - Featured Research .. d Pharmaceuticals, Inc. and Gilead Sciences, Inc.
[ Mon, Nov 21st 2011 ] - Market Wire
InSite Vision to Present at the 23rd Annual Piper Jaffray Health Care Conference
[ Mon, Nov 21st 2011 ] - Market Wire
Tengion to Present at Piper Jaffray 23rd Annual Health Care Conference
[ Mon, Nov 21st 2011 ] - Market Wire
Dendreon Announces the Centers for Medicare and M .. ow Cover Infusion Costs Associated with the Admin
[ Mon, Nov 21st 2011 ] - Market Wire
Research on Health Management Associates Inc. and .. . -- Healthcare Hospitals Report Mixed Q3 Results
[ Mon, Nov 21st 2011 ] - Market Wire
Celldex Therapeutics Reports Positive Mature Surv .. ndopepimut Phase 2 Brain Cancer Study at SNO 2011
[ Mon, Nov 21st 2011 ] - Market Wire
REVLIMID riceve approvazione di Swissmedic per il trattamento di un raro cancro del sangue
[ Mon, Nov 21st 2011 ] - Market Wire
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot
[ Mon, Nov 21st 2011 ] - Market Wire
Oncolytics Biotech Inc. Announces Start of Conformity Testing with SAFC
[ Mon, Nov 21st 2011 ] - Market Wire
Implant Sciences' Quantum Sniffer(TM) Explosives .. New Mobile Airfreight Screening Business in Germa
[ Mon, Nov 21st 2011 ] - Market Wire
ArthroCare Announces Participation in Investor Conference
[ Mon, Nov 21st 2011 ] - Market Wire
BioDelivery Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Mon, Nov 21st 2011 ] - Market Wire
Adeona Pharmaceuticals and Intrexon Announce Worl .. for Synthetic DNA-based Therapy for Pulmonary Ar
[ Mon, Nov 21st 2011 ] - Market Wire
Preclinical Darinaparsin Study in PLoS ONE Publication
[ Mon, Nov 21st 2011 ] - Market Wire
Health Management Associates, Inc. Announces Clos .. ties, Private $875 Million Debt Offering and GAAP
[ Mon, Nov 21st 2011 ] - Market Wire
OncoSec Appoints Scientific Advisory Board
[ Mon, Nov 21st 2011 ] - Market Wire
Exelixis Announces Initiation of Phase 2 Investig .. antinib in Women with Hormone Receptor-Positive M
[ Mon, Nov 21st 2011 ] - Market Wire
PowerVerde Announces Binding Letter of Intent to .. tion Group, a Technology and Distribution Company
[ Mon, Nov 21st 2011 ] - Market Wire
Perceptive Informatics Global Survey Results Indi .. ndard Medical Imaging Metrics to Meet Study Miles
[ Mon, Nov 21st 2011 ] - Market Wire
Alnylam Presents Positive Preliminary Clinical Re .. Therapeutic for the Treatment of Transthyretin-Me
[ Mon, Nov 21st 2011 ] - Market Wire
Comprehensive Care Corporation Announces Nine Month Revenues Top $54 Million, up 212 Percent
Sun, November 20, 2011
[ Sun, Nov 20th 2011 ] - Market Wire
Valeant Pharmaceuticals Agrees to Acquire iNova
[ Sun, Nov 20th 2011 ] - Market Wire
CML HealthCare Inc. Declares November Dividend

PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011


//health-fitness.news-articles.net/content/2011/ .. l-healthcare-conference-on-november-30-2011.html
Published in Health and Fitness on Monday, November 28th 2011 at 7:20 GMT by Market Wire   Print publication without navigation


PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on... -- ANNAPOLIS, Md., Nov. 28, 2011 /PRNewswire/ --

PharmAthene to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011

[ ]

ANNAPOLIS, Md., Nov. 28, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: [ PIP ]), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that Eric I. Richman, President and Chief Executive Officer will present at the Piper Jaffray 23rd Annual Healthcare Conference being held November 29-30, 2011. 

Mr. Richman will also be available to participate in one-on-one meetings at the conference.

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

Event:

Piper Jaffray Healthcare Conference

Date:

Wednesday, November 30, 2011

Place:

New York Palace Hotel, Kennedy One Room, 455 Madison Ave, New York, NY

Time:

12:30 pm ET

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax™ - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Recombinant BChE- a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

In addition, pursuant to an opinion issued September 22, 2011 from the Delaware Court of Chancery, PharmAthene is entitled to 50% of the profits over 10 years from all sales of SIGA Technologies' ST-246, and related products, a novel smallpox antiviral agent being developed by SIGA for the treatment and prevention of morbidity and mortality associated with exposure to the causative agent of smallpox (once SIGA receives the first $40 million in net profits from sales of ST-246.)

For more information about PharmAthene, please visit [ www.PharmAthene.com ].

SOURCE PharmAthene, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.pharmathene.com ]


Publication Contributing Sources